Form 4: Standex Director Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Standex International Director Thomas E. Chorman sold 50 shares of common stock for $249.86 per share under a pre-arranged 10b5-1 plan.
Summary
- Thomas E. Chorman, a Director of Standex International Corporation (SXI), reported a sale of common stock.
- The transaction involved the disposition of 50 shares of common stock.
- The shares were sold at a price of $249.86 per share.
- The sale was executed on February 4, 2026.
- This transaction was conducted pursuant to an existing Rule 10b5-1 trading plan, which was dated November 6, 2025.
- Following this transaction, Thomas E. Chorman directly beneficially owns 13,179 shares of Standex International common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event. The sale is a routine insider transaction under a pre-arranged 10b5-1 plan, which typically does not indicate a change in management's sentiment about the company's future.
Future Outlook
The filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.
Industry Context
StockSavvy.ai notes that insider sales executed under Rule 10b5-1 plans are common and typically pre-scheduled, often for personal financial planning or diversification. Such transactions generally carry less signaling weight regarding management's view of the company's future prospects compared to open market sales not under a plan.
Stakeholder Impact
- Shareholders: Minimal impact as this is a routine, pre-planned insider sale and does not suggest a change in company fundamentals or outlook.
Key Dates
| Date | Description |
|---|---|
| November 6, 2025 | Date of the existing 10b5-1 trading plan. |
| February 4, 2026 | Date of the reported stock transaction (sale). |
| February 5, 2026 | Date the Form 4 filing was signed. |
Recommendation
holdThe sale by Director Thomas E. Chorman was executed under a pre-arranged 10b5-1 trading plan, which typically indicates a planned liquidity event rather than a change in sentiment regarding the company's future prospects. Such routine transactions generally do not provide a strong signal for investors to alter their positions, hence a 'hold' recommendation is appropriate.
Keywords
Standex International, SXI, Form 4, Insider Trading, Stock Sale, 10b5-1 Plan, Director Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.